Rexulti 0.5 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FJA0B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,708
Award facts
- Contract value 100% obligated
- $13,708.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13.7K to AmerisourceBergen Drug Corp for supply of Rexulti 0.5 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, due for completion on November 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill performance at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of medications and medical commodities to military healthcare programs worldwide.
AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency covering a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The DLA Troop Support Medical IDC enables the contractor to supply customers including the Defense Health Agency and U.S. Coast Guard, with the agency planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts through multiple regional awards in the coming years.
Quick answers
Who was awarded contract SPE2DR26FJA0B?
SPE2DR26FJA0B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FJA0B worth?
The government has obligated $13,708 on SPE2DR26FJA0B.
Is contract SPE2DR26FJA0B an order under another contract?
Yes. SPE2DR26FJA0B is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJA0B competed?
The extent of competition for SPE2DR26FJA0B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award